Evidence-based criteria that drive decision-making across windows.
Time windows
IV thrombolysis: strongest evidence ≤4.5 h from last-known-well [7], [8], [9]
EVT: standard ≤6 h for anterior-circulation LVO [1]
Late-window EVT: 6–16 h (DEFUSE 3) and 6–24 h (DAWN) with imaging selection [1], [6]
Imaging selection
NCCT to exclude hemorrhage; CTA to confirm LVO [5], [10]
Perfusion CT/MR to define core/penumbra and clinical–imaging mismatch in late window [1], [6]
Use standardized thresholds and automated software when available to reduce delays [6]
IVT pearls
Administer promptly when eligible; benefits include improved reperfusion and functional outcomes in early window [8], [9]
Do not delay for EVT workup—start IVT while arranging endovascular care (bridging) [7], [8]
Tenecteplase is an accepted alternative in many systems; follow local protocols [7]
EVT indications
Anterior-circulation LVO (ICA terminus/M1) with disabling deficits; consider M2/posterior on case-by-case basis [1], [10]
Late window requires small core and substantial penumbra or clinical–core mismatch (e.g., DAWN/DEFUSE 3) [1], [6]
Aim for fast puncture-to-reperfusion times; first-pass effect improves outcomes
Bridging vs direct EVT
DIRECT-MT and SKIP suggest non-inferiority of direct EVT on 90-day mRS in specific Asian cohorts; global generalizability is debated [2]
Meta-analyses show similar functional outcomes but nuanced differences in early reperfusion and symptomatic ICH; protocolize per system [3], [4]
If IVT eligible and no significant delay, many centers still favor bridging to maximize early recanalization [8], [3]
Systems and equity
Prehospital LVO routing and ED ‘code-LVO’ pathways shorten time-to-treatment and improve outcomes [5], [11]
Access gaps persist; organized transfer networks are critical to deliver EVT benefits broadly [11], [12], [10]